Skip to content

    Recently Viewed

      Listening...

      Home / Our Company /
      How we innovate to beat NTDs from the lab to the last mile
      Group of seated woman taken from video segment discussing global public health and the fight against neglected tropical diseases (NTDs)
      Our Company

      How we innovate to beat NTDs from the lab to the last mile

      Share Article
      share to

      For more than 15 years, Johnson & Johnson has been at the forefront of global efforts to beat neglected tropical diseases (NTDs), proudly donating more than two billion doses of mebendazole for the treatment of intestinal worms to field partners in more than 50 countries. Through tireless and collaborative efforts, countless children in need have been given the opportunity to recover, play, learn – and thrive. Now, in addition to enabling access to our medicine for even more children, we’re also advancing novel R&D programs to discover new medicines needed to beat dengue and leprosy.

      We have an historic opportunity to unlock the potential of hundreds of millions of lives and create a prosperous and safer future for communities across the globe. That is why we are in this fight and invite you to join us in beating NTDs. To learn more, visit JNJ.com/NTDs.

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.